Crystal structure of oligomeric β 1-adrenergic G protein-coupled receptors in ligand-free basal state

Nature Structural and Molecular Biology

Volumn 20, Issue 4, 2013, Pages 419-425

  Huang, Jianyun ^a   Chen, Shuai ^a   Zhang, J Jillian ^a   Huang, Xin Yun ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; DIMER; G PROTEIN COUPLED RECEPTOR; LIGAND;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; DIMERIZATION; LIPID MEMBRANE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; X RAY;

BIOPOLYMERS; DIMERIZATION; DISULFIDES; LIGANDS; MODELS, MOLECULAR; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84876197291     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.2504     Document Type: Article

References (51)

1. Pierce, K.L., Premont, R.T. & Lefkowitz, R.J. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3, 639-650 (2002).
2. Oldham, W.M. & Hamm, H.E. Heterotrimeric G protein activation by G-protein-coupled receptors. Nat. Rev. Mol. Cell Biol. 9, 60-71 (2008).
3. Vassart, G. & Costagliola, S. G protein-coupled receptors: mutations and endocrine diseases. Nat. Rev. Endocrinol. 7, 362-372 (2011).
4. Kenakin, T. & Miller, L.J. Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol. Rev. 62, 265-304 (2010).
5. Lappano, R. & Maggiolini, M. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat. Rev. Drug Discov. 10, 47-60 (2011).
6. Brunton, L. Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th edn (McGraw-Hill Professional, 2010).
7. Palczewski, K. et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739-745 (2000).
8. Cherezov, V. et al. High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science 318, 1258-1265 (2007).
9. Rasmussen, S.G. et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor. Nature 450, 383-387 (2007).
10. Warne, T. et al. Structure of a β1-adrenergic G-protein-coupled receptor. Nature 454, 486-491 (2008).
11. Jaakola, V.P. et al. The 2.6 Å crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322, 1211-1217 (2008).
12. Park, J.H., Scheerer, P., Hofmann, K.P., Choe, H.W. & Ernst, O.P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 454, 183-187 (2008).
13. Scheerer, P. et al. Crystal structure of opsin in its G-protein-interacting conformation. Nature 455, 497-502 (2008).
14. Murakami, M. & Kouyama, T. Crystal structure of squid rhodopsin. Nature 453, 363-367 (2008).
15. Wu, B. et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330, 1066-1071 (2010).
16. Chien, E.Y. et al. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 330, 1091-1095 (2010).
17. Rasmussen, S.G. et al. Structure of a nanobody-stabilized active state of the β(2) adrenoceptor. Nature 469, 175-180 (2011).
18. Warne, T. et al. The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor. Nature 469, 241-244 (2011).
19. Shimamura, T. et al. Structure of the human histamine H(1) receptor complex with doxepin. Nature 475, 65-70 (2011).
20. Xu, F. et al. Structure of an agonist-bound human A2A adenosine receptor. Science 332, 322-327 (2011).
21. Lebon, G. et al. Agonist-bound adenosine A(2A) receptor structures reveal common features of GPCR activation. Nature 474, 521-525 (2011).
22. Choe, H.W. et al. Crystal structure of metarhodopsin II. Nature 471, 651-655 (2011).
23. Standfuss, J. et al. The structural basis of agonist-induced activation in constitutively active rhodopsin. Nature 471, 656-660 (2011).
24. Rasmussen, S.G. et al. Crystal structure of the β2 adrenergic receptor-Gs protein complex. Nature 477, 549-555 (2011).
25. Sakmar, T.P. Structure of rhodopsin and the superfamily of seven-helical receptors: the same and not the same. Curr. Opin. Cell Biol. 14, 189-195 (2002).
26. Angers, S., Salahpour, A. & Bouvier, M. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42, 409-435 (2002).
27. Filizola, M. & Weinstein, H. The study of G-protein coupled receptor oligomerization with computational modeling and bioinformatics. FEBS J. 272, 2926-2938 (2005).
28. Milligan, G. The role of dimerisation in the cellular traffcking of G-protein-coupled receptors. Curr. Opin. Pharmacol. 10, 23-29 (2010).
29. Palczewski, K. Oligomeric forms of G protein-coupled receptors (GPCRs). Trends Biochem. Sci. 35, 595-600 (2010).
30. Klco, J.M., Lassere, T.B. & Baranski, T.J. C5a receptor oligomerization. I. Disulfde trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor. J. Biol. Chem. 278, 35345-35353 (2003).
31. Guo, W. et al. Dopamine D2 receptors form higher order oligomers at physiological expression levels. EMBO J. 27, 2293-2304 (2008).
32. Liang, Y. et al. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J. Biol. Chem. 278, 21655-21662 (2003).
33. Kota, P., Reeves, P.J., Rajbhandary, U.L. & Khorana, H.G. Opsin is present as dimers in COS1 cells: identifcation of amino acids at the dimeric interface. Proc. Natl. Acad. Sci. USA 103, 3054-3059 (2006).
34. Han, Y., Moreira, I.S., Urizar, E., Weinstein, H. & Javitch, J.A. Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation. Nat. Chem. Biol. 5, 688-695 (2009).
35. Bouvier, M. Oligomerization of G-protein-coupled transmitter receptors. Nat. Rev. Neurosci. 2, 274-286 (2001).
36. Lohse, M.J. Dimerization in GPCR mobility and signaling. Curr. Opin. Pharmacol. 10, 53-58 (2010).
37. Mercier, J.F., Salahpour, A., Angers, S., Breit, A. & Bouvier, M. Quantitative assessment of p1-and p2-adrenergic receptor homo-and heterodimerization by bioluminescence resonance energy transfer. J. Biol. Chem. 277, 44925-44931 (2002).
38. Kobayashi, H., Ogawa, K., Yao, R., Lichtarge, O. & Bouvier, M. Functional rescue of p-adrenoceptor dimerization and traffcking by pharmacological chaperones. Traffc 10, 1019-1033 (2009).
39. Guo, W., Shi, L. & Javitch, J.A. The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. J. Biol. Chem. 278, 4385-4388 (2003).
40. Guo, W., Shi, L, Filizola, M., Weinstein, H. & Javitch, J.A. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc. Natl. Acad. Sci. USA 102, 17495-17500 (2005).
41. Mancia, F., Assur, Z., Herman, A.G., Siegel, R. & Hendrickson, W.A. Ligand sensitivity in dimeric associations of the serotonin 5HT2c receptor. EMBO Rep. 9, 363-369 (2008).
42. Ballesteros, J.A. & Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 25, 366-428 (1995).
43. Moukhametzianov, R. et al. Two distinct conformations of helix 6 observed in antagonist-bound structures of a p1-adrenergic receptor. Proc. Natl. Acad. Sci. USA 108, 8228-8232 (2011).
44. Baker, J.G., Proudman, R.G. & Tate, C.G. The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (p36) deletions essential for crystallisation of the turkey p-adrenoceptor. Naunyn Schmiedebergs Arch. Pharmacol. 384, 71-91 (2011).
45. Salom, D. et al. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proc. Natl. Acad. Sci. USA 103, 16123-16128 (2006).
46. Wu, H. et al. Structure of the human K-opioid receptor in complex with JDTic. Nature 485, 327-332 (2012).
47. Manglik, A. et al. Crystal structure of the |i-opioid receptor bound to a morphinan antagonist. Nature 485, 321-326 (2012).
48. Smith, N.J. & Milligan, G. Allostery at G protein-coupled receptor homo-and heteromers: uncharted pharmacological landscapes. Pharmacol. Rev. 62, 701-725 (2010).
49. Hebert, T.E. et al. A peptide derived from a p2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 271, 16384-16392 (1996).
50. Fung, J.J. et al. Ligand-regulated oligomerization of p(2)-adrenoceptors in a model lipid bilayer. EMBO J. 28, 3315-3328 (2009).
51. Damian, M., Martin, A., Mesnier, D., Pin, J.P. & Baneres, J.L. Asymmetric conformational changes in a GPCR dimer controlled by G-proteins. EMBO J. 25, 5693-5702 (2006).